| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |